Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats

doi:10.3748/wjg.14.4546

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3566)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

321

HTML

2812

Figures (1-2)

260

Tables (1-1)

173

Sum=3566

Jul 28, 2008 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jul 28, 2008; 14(28): 4546-4550
Published online Jul 28, 2008. doi: 10.3748/wjg.14.4546

Full Size Figure Download Figure

Figure 1 Serum HMGB1 levels of rats. Group I: Sham group; Group II: Delayed EP treatment group; Group III: SAP group. ^bP < 0.01 vs Group I; ^dP < 0.01 vs Group II.

Citation: Yang ZY, Ling Y, Yin T, Tao J, Xiong JX, Wu HS, Wang CY. Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats. World J Gastroenterol 2008; 14(28): 4546-4550
URL: https://www.wjgnet.com/1007-9327/full/v14/i28/4546.htm
DOI: https://dx.doi.org/10.3748/wjg.14.4546